• Home News Sun Pharma Launches Drizalma Sprinkle now the U.S.

Sun Pharma Launches Drizalma Sprinkle now the U.S.

Posted 16 Oct-2019 11:36 AM by Vinita | 146


MUMBAI, India & PRINCETON, N.J.--(Press Release Power)--Sun Pharmaceutical Productions Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUN PHARMA, BSE: 524715, “Sun Pharma” excluding its and/or associate companies) today announced that one of its absolutely owned branches has launched Drizalma Sprinkle™ (duloxetine delayed-release capsules) in the U.S. for oral use. Drizalma Sprinkle is a serotonin and norepinephrine reuptake inhibitor (SNRI) designed for the treatment of various neuropsychiatric and pain illnesses in patients who have difficulty swallowing – a problem that is expected to affect approximately 30-35% of long-term care residents. The U.S. Food and Drug Administration (FDA) appropriate Drizalma Sprinkle on July 19, 2019.

“The launch of Drizalma Sprinkle is an important milestone for people with difficulty swallowing, as this formulation of duloxetine can facilitate treatment of common neuropsychiatric disorders while preserving the quality of the medicine”

The availability of Drizalma Sprinkle expands Sun Pharma’s assortment of alternative formulation products designed for beings with swallowing difficulties, the risk of which increases with age and exposure to age-related diseases and conditions - including depression, anxiety, and pain disorders.1-2 Drizalma Sprinkle joins Ezallor Sprinkle™ (Rosuvastatin) and Kapspargo Sprinkle™ (metoprolol succinate) extended-release capsules as the third product in Sun Pharma’s US portfolio designed for individuals in long-term care. It is common practice in long-term care facilities to crush medications to ease administration, but crushing tablets introduces additional risks into the administration process.3 The Joint Commission International Accreditation Standards for Long Term Care urges facilities to dispense medications in forms that require minimal manipulation.4

“The launch of Drizalma Sprinkle is an important milestone for people with difficulty swallowing, as this formulation of duloxetine can facilitate treatment of common neuropsychiatric disorders while preserving the quality of the medicine,” said Abhay Gandhi, CEO, North America, Sun Pharma. ”This launch further underscores our commitment to providing a portfolio of alternative formulation products to treat common diseases – especially in long-term care, where 30-35% of individuals have difficulty swallowing. These patients often encounter medication errors and challenges with medication administration.”

Drizalma Sprinkle is indicated for the treatment of the major depressive disorder (MDD) in adults, generalized anxiety disorder (GAD) in adults and pediatric patients 7-17 years old, diabetic peripheral neuropathic pain (DPNP) in adults, and chronic musculoskeletal pain in adults. It is available in four dosage strengths (20mg, 30mg, 40mg, and 60mg). Drizalma Sprinkle is the first and only FDA-approved formulation of duloxetine that can be swallowed whole, sprinkled on applesauce or administered via nasogastric tube.

Drizalma Sprinkle carries a boxed warning for suicidal thoughts and behaviours. In clinical trials of Drizalma Sprinkle, the most common adverse reactions (in at least 5% of participants and at least twice the incidence of placebo) were nausea, dry mouth, somnolence, constipation, decreased appetite, and hyperhidrosis.


INDICATIONS AND USAGE

Drizalma Sprinkle (duloxetine delayed-release capsules) for oral use is indicated for the treatment of major depressive disorder in adults; generalized anxiety disorder in adults and pediatric patients aged 7 to 17 years; diabetic peripheral neuropathy in adults, and chronic musculoskeletal pain in adults.

IMPORTANT SAFETY INFORMATION

WARNING: SUICIDAL THOUGHTS AND BEHAVIORS: Antidepressants increased the risk of suicidal thoughts and behaviour in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening and for the emergence of suicidal thoughts and behaviors.

Contraindications

Serotonin syndrome and MAOIs: Do not use MAOIs intended to treat psychiatric disorders with Drizalma Sprinkle or inside 5 days of stopping treatment with Drizalma Sprinkle. Do not use Drizalma Sprinkle within 14 days of stopping an MAOI intended to treat psychiatric disorders. In addition, do not start Drizalma Sprinkle in a patient who is being treated with linezolid or intravenous methylene blue.

WARNINGS AND PRECAUTIONS

Hepatotoxicity: Hepatic failure, sometimes fatal, has been reported in patients treated with duloxetine delayed-release capsules. Duloxetine delayed-release capsules should be discontinued in patients who develop jaundice or other evidence of clinically significant liver dysfunction and should not be resumed unless another cause can be established. Drizalma Sprinkle should not be prescribed to patients with substantial alcohol use or evidence of chronic liver disease.

Orthostatic Hypotension, Falls, and Syncope: Cases have been reported with duloxetine delayed-release capsules therapy. Syncope and orthostatic hypotension tend to occur within the first week of therapy but can occur at any time during treatment, particularly after dose increases.

Serotonin Syndrome: There is increased risk when coadministered with other serotonergic agents (eg, SSRIs, SNRIs, triptans), but also when taken alone. The concomitant use of Drizalma Sprinkle with MAOIs is contraindicated. Do not initiate Drizalma Sprinkle in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue. Monitor all patients taking Drizalma Sprinkle™ for the emergence of serotonin syndrome. If it occurs, discontinue Drizalma Sprinkle and initiate supportive treatment.

Increased Risk of Bleeding: Duloxetine may increase the risk of bleeding events. Concomitant use of NSAIDs, aspirin, other antiplatelet drugs, warfarin, and anticoagulants may increase this risk.

Severe Skin Reactions: Severe skin reactions, including erythema multiforme and Stevens-Johnson Syndrome, can occur with duloxetine. Drizalma Sprinkle should be discontinued at the first appearance of blisters, peeling rash, mucosal erosions, or any other sign of hypersensitivity if no other aetiology can be identified.

Discontinuation Syndrome: Adverse reactions after discontinuation of serotonergic antidepressants, particularly after abrupt discontinuation, include nausea, sweating, dysphoric mood, irritability, agitation, dizziness, sensory disturbances (e.g., paresthesias, such as electric shock sensations), tremor, anxiety, confusion, headache, lethargy, emotional lability, insomnia, hypomania, tinnitus, and seizures. A gradual reduction in dosage rather than abrupt cessation is recommended whenever possible.

Activation of Mania or Hypomania: In patients with bipolar disorder, treating a depressive episode with duloxetine delayed-release capsules or another antidepressant may precipitate a mixed/manic episode. Use cautiously in patients with bipolar disorder. Prior to initiating treatment with Drizalma Sprinkle, screen patients for any personal or family history of bipolar disorder, mania, or hypomania.

Angle-Closure Glaucoma: Duloxetine may trigger an angle-closure attack in patients with anatomically narrow angles who do not have a patent iridectomy. Avoid the use of antidepressants, including Drizalma Sprinkle, in patients with anatomically narrow angles.

Seizures: Drizalma Sprinkle should be prescribed with care in patients with a history of seizure disorder.

Blood Pressure: Monitor blood pressure prior to initiating treatment and periodically throughout treatment.

Hyponatremia: Can occur in association with SIADH. Cases of hyponatremia have been reported.

Glucose Control in Diabetes: In diabetic peripheral neuropathic pain patients, small increases in fasting blood glucose and HbA1c have been observed.

ADVERSE REACTIONS

The most common adverse reactions (≥5% and at least twice the incidence of placebo patients) were nausea, dry mouth, somnolence, constipation, decreased appetite, and hyperhidrosis.

DOSING AND ADMINISTRATION

Drizalma Sprinkle may be taken with or without food. Drizalma Sprinkle may be swallowed whole (do not crush or chew capsule); opened and sprinkled over applesauce; or administered via nasogastric tube.

DRUG INTERACTIONS

Avoid concomitant use with potent CYP1A2 inhibitors.
Consider dose reduction with concomitant use with CYP2D6 substrates.
USE IN SPECIFIC POPULATIONS

Hepatic Impairment: Avoid use in patients with mild, moderate, or severe hepatic impairment.

Renal Impairment: Avoid use in patients with severe renal impairment.

Pregnancy: Advise patients to notify their healthcare provider if they become pregnant or intend to become pregnant during treatment with Drizalma Sprinkle. Third-trimester use may increase the risk of symptoms of poor adaptation (respiratory distress, temperature instability, feeding difficulty, hypotonia, tremor, irritability) in the neonate.

Please see Full Prescribing Information by clicking here.

References:
1. Zis, P, Daskalaki, A, Bountouni, I, Sykioti, P, Varrassi, G, Paladini, A. Depression and chronic pain in the elderly: links and management challenges. Clinical Interventions in Aging. 2017;12:709–720. DOI: 10.2147/CIA.S113576.

2. Wolitzky-Taylor KB, Castriotta N, Lenze EJ, Stanley MA, Craske MG. Anxiety disorders in older adults: a comprehensive review. Depression and Anxiety. 2010;27(2):190-211. doi:10.1002/da.20653.

3. Hughes, PJ, Freeman, MK, Slaton, RM. Common Issues in the medication use processes in nursing homes: a review of medication use quality improvement strategies. Journal of Nursing Education and Practice. 2016;6(7):81-90. DOI: 10.5430/jnep.v6n7p81

4. Joint Commission International. Joint Commission International Endorsement Standards for Long Term Care. 1st ed. Oak Brook, IL: Joint Commission International; 2012.

Contacts
Media:
Vinita Alexander
Tel: 609-720-8197

Reba Auslander
Tel Direct 917-836-9308

For more information about Drizalma Sprinkle, visit DrizalmaSprinkle.com



Company Information

Company Name Contact Person Contact Number Email Id Website
Sun Pharma Vinita Alexander 6097208197 [email protected] http://stage.drizalmasprinkle.com/

Latest News

Ketsaal : kitchen and home appliances franchise Excluive

 Expecting to connect with more clients the nation over propelled its franchisee program, which is totally different from how marks by and large uti...Read More


Stringent Government Rules and Regulations to Drive the Water Control Valve Market Excluive

“Water Control Valve Market – Global Industry Dynamics 2018-19, Trends and Forecast, 2020–2027” is an upcoming market research report added by...Read More


Social Distancing Sign Solutions - Webster Printing Rolls Out New Division Excluive

Hanover and Hanson, MA, March 31, 2020 -- As companies strive to ensure the safety of their customers and employees by following the guidelines of pub...Read More


Robust Penetration of Smartphones to Offer Lucrative Opportunities to the Marine Audio Equipment Market Excluive

“Marine Audio Equipment Market – Global Industry Dynamics 2018-19, Trends and Forecast, 2020–2027” is an upcoming market research report add...Read More


Innovation in Product Designs and Materials to Drive the Wrenches Market Excluive

“Wrenches Market – Global Industry Dynamics 2018-19, Trends and Forecast, 2020–2027” is an upcoming market research report added by the analys...Read More


A Brutally Forthright Exposure of World Apathy Towards Corruption and Endless Conflicts Excluive

London, England, Mar 28, 2020 -- Freelance war correspondent Mike Walker's reporting of the truth is becoming increasingly difficult and dangerous in ...Read More


Mapping Company Educates Readers On Sales Territory Mapping Excluive

Wake Forest, North Carolina (pressreleasepower) March 26, 2020 - Geographic Enterprises, a North Carolina mapping company, recently discussed the...Read More


Credihealth launches dedicated tele/video consultation service Excluive

March 26, 2019, New Delhi: Credihealth, India’s first digital health gateway, announced its launch of a dedicated tele/ video consultation service w...Read More


Marketing Funnels - Ultimate Funnels Cracks The Code Helps Online Businesses Grow 10x's Faster Excluive

Sales Funnel experts Lavell Frost and Rajeev Kistoo reveal their formula for building funnels that convert. Every online business selling something ne...Read More


Transport Canada Gives STC Approval On Next Generation Exhaust Stacks DHC-6 Series Twin Otter Aircraft to Acorn Welding Ltd Excluive

EDMONTON, Alberta, March 24, 2020: Acorn Welding Ltd has received STC approval from Transport Canada on new, Next Generation exhaust stacks for the DH...Read More


Demand for Eco-friendly Hunting Gear to Create Significant Opportunity for the Hunting Gear Market Excluive

“Hunting Gear Market – Global Industry Dynamics 2018-19, Trends and Forecast, 2020–2027” is an upcoming market research report added by the an...Read More


Ketsaal : kitchen appliances franchise l kitchen franchise business Excluive

Expecting to connect with more clients the nation over propelled its franchisee program, which is totally different from how marks by and large utiliz...Read More


7th International Conference on COPD and Lung Health Excluive

COPD 2020 Congress aims to bring together the prominent researchers, academic scientists, and research scholars to exchange and share their expe...Read More


Gong Cha Announces A New Store In New Jersey With Buy 1 Get 1 Free On Select Items Excluive

New York, USA - Gong Cha is pleased to announce that its Montclair bubble tea store, NJ location is now open! And esteemed customers can quickly enjoy...Read More


Manhattan Commercial HVAC Contractors Discuss Evaporator Coil Leaks Excluive

Manhattan, New York (pressreleasepower) March 23, 2020 - Cool Works Co., a Manhattan commercial HVAC contractor, recently released a blog educati...Read More


Increasing Spending on Recreational Activities to Fuel the Archery Equipment Market Excluive

“Archery Equipment Market – Global Industry Dynamics 2018-19, Trends and Forecast, 2020–2027” is an upcoming market research report added by t...Read More


Indiana Hospice Educates On The Benefits Of Hospice Care For Aids Patients Excluive

Indianapolis, Indiana (pressreleasepower) March 21, 2020 - Harbor Light Hospice, an Indiana hospice, recently shared a blog informing people about the...Read More


Bruneau & Co. Auctioneers will Hold a Spring Comic Book & Toy Auction on Saturday, April 4, Online and in Cranston, RI Excluive

The auction will be held online and in Bruneau & Co’s gallery at 63 Fourth Avenue in Cranston. Sold will be graded comic books, comic art, Japan...Read More


Paintings by Indian Artists Maqbool Hussain, B. Prabha, Akbar Padamsee Top Bruneau & Co. Auction Held March 14 Excluive

Cranston, RI, USA, March 20, 2020 -- Vibrant paintings by prominent Indian artists piqued the interest of bidders at Bruneau & Co. Auctioneers’ ...Read More


Ireland Just Got Deeper as Newcomer Artist Daniela Introduces her Powerful Debut EP Kiss Excluive

Hailing from Ireland, Daniela is a talented singer and songwriter with a passion for beautiful melodies and relatable sonic aesthetics. Recently, she ...Read More


Fresh Series Of Strawberry Flavor Available At The Gong Cha's New Jersey Franchise Excluive

New York, USA - Gong Cha is happy to announce the grand opening of its new franchise in New Jersey with fresh strawberry series. The new store feature...Read More


Recent Releases